Lek once again awarded the Family Friendly Company certificate
- Lek has been awarded the Family Friendly Company certificate for the eighteenth consecutive year.
- Lek has been involved in the Family Friendly initiative since the project began. In 2007, it was among the first in Slovenia to receive the certificate.
- The Family Friendly Company certificate reflects Lek's efforts to balance professional and private life and to provide conditions that facilitate the harmonization of work commitments with the needs of family life.
Lek, a Sandoz company, was awarded the "Family Friendly Company" certificate by the Institute for Labor and the Ministry of Labor. This is an acknowledgement of Lek's commitment to improving the work-life balance of its people.
"Receiving the Family Friendly Company certificate is an acknowledgement of our efforts to create a working environment that supports both the professional and private lives of our people. At Lek, we recognize the importance of balance in life and strive to create and maintain a working environment based on the satisfaction and wellbeing of our associates. Our purpose is not only to pioneer access for patients, but also to support our people at the leading edge," said Gregor Makuc, Head Corporate Affairs and Member of the Lek d.d. Board of Management.
Lek demonstrates its commitment to creating a work environment that is friendly to its associates and their families through a number of family-friendly practices. Associates for whom their work allows it have the option of working from home and flexible hours, with a choice of start and finish times. The company also organizes special family days for the families of its associates at all Lek sites.
Associates also receive additional benefits. The Energized for Life wellbeing program helps associates achieve a healthy work-life balance, and the company also offers a range of educational, professional and personal development opportunities in a global pharmaceutical company.
Lek has received a total of four full Family Friendly Company certificates, and in 2022, on the occasion of the 15th anniversary of the certificate, they received a special award as representatives of the first generation of recipients.
About Lek
Lek, a Sandoz company, is the first and oldest pharmaceutical company in Slovenia, developing, manufacturing and marketing effective, safe and high-quality generics and biosimilars for patients around the world. Our work is guided by strong ethical standards, innovative thinking and the breakthrough achievements of our world-class professionals. With more than 3,700 associates, we have been actively shaping the Slovenian, European and global research and development landscape for decades. We are building a culture of open dialog, and we proudly and responsibly hold the title of most reputable employer in Slovenia.
About Sandoz
Sandoz (SIX: SDZ; OTCQX: SDZNY) is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work together to ensure 800 million patient treatments are provided by Sandoz, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1500 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the first biosimilar in 2006. In 2023, Sandoz recorded sales of USD 9.6 billion.
Disclaimer
This Media Release contains forward-looking statements which offer no guarantee with regard to future performance. These statements are made on the basis of management’s views and assumptions regarding future events and business performance at the time the statements are made. They are subject to risks and uncertainties including, but not confined to, future global economic conditions, exchange rates, legal provisions, market conditions, activities by competitors and other factors outside of the control of Sandoz. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual outcomes may vary materially from those forecasted or expected. Each forward-looking statement speaks only as of the date of the particular statement, and Sandoz undertakes no obligation to publicly update or revise any forward-looking statements, except as required by law.
